Small molecule pharmaceutical products are assumed to reach concentrations in semen similar to those in blood plasma.
Potential Seminal Transport of Pharmaceuticals to the Conceptus
Reproductive Toxicology, 2015
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Reproductive Toxicology, 2015
Small molecule pharmaceutical products are assumed to reach concentrations in semen similar to those in blood plasma.
Frontiers in Pharmacology, 2023
In response to the increase use of novel anti-viral drugs for COVID, experts from our Botanical Safety Consortium have put out a review article that presents data on regionally-relevant herbal medicine use that have the potential for herbal medicine interaction (HDI).
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2006
The objective of this report is to summarize the available literature regarding the postnatal growth and morphological development of the brain and compare the timelines for these events between humans and experimental species.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2005
To view the full citation, click here.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
To view the full citation, click here.
Environmental Health Perspectives, 2006
The use of biomonitoring data holds promise for characterizing exposure and informing risk assessment.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.